The Bio One-on-One Partnering in the BIO Business Forum is an all day partnering session, Monday through Friday, AND sponsored only by Merck.
Guess who is partnering with Anavex next month at a conference co-paneling a discussion about precision medicine in psychiatric diseases? Merck.
Guess who is a member alongside Anavex in the newly formed consortium on Schizophrenia? Merck
Guess who funded the preclinical findings on Anavex 371? Merck
Anavex has an aresenal of tools at a partnering session with Merck. They fund our precilinal trial, they join an exclusive group with us, and they agree to co-panel a discussion in July with us to wrap up a conference. That's a lot of goodness in partnership discussions in Philly. I think Anavex will announce a partnership with Merck first week in June. IMO
Anavex market cap around $140M. That is an afternoon snack for somebody like Merck, and that's what makes the risk/return here unbelievable to me. I know the market as NOT connected the dots; because if it did the stock would shoot up to $15 in a matter of minutes.
I believe Anavex sent the proxy postcard to shareholders asking us to vote for the preferred explicitly to thwart an unwanted takeover after the official mailing of proxy materials because somebody like Merck (I think it's actually Merck) had expressed interest, was in conversations with Anavex, and Missling saw what was coming...
Remember, the consortium news, the co-paneling with Merck news, and the funding by Merck of 371 is all known prior to Anavex sending out that postcard to shareholders. Anavex exposed themselves legally by sending that mailing. I believe it's real because I believe the company has acted in good faith. Keeping everything hush hush for so long shows the integrity of Anavex.
Somebody big is on the hunt....they want Anavex.
